A Teh

ORCID: 0000-0002-8811-3135
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Hematopoietic Stem Cell Transplantation
  • Acute Lymphoblastic Leukemia research
  • Acute Myeloid Leukemia Research
  • Pregnancy and preeclampsia studies
  • Lymphoma Diagnosis and Treatment
  • Chronic Lymphocytic Leukemia Research
  • Immune Cell Function and Interaction
  • Chronic Myeloid Leukemia Treatments
  • Retinoids in leukemia and cellular processes
  • Immunodeficiency and Autoimmune Disorders
  • Pharmacogenetics and Drug Metabolism
  • Hemophilia Treatment and Research
  • Transplantation: Methods and Outcomes
  • Neutropenia and Cancer Infections
  • Blood Coagulation and Thrombosis Mechanisms
  • Eosinophilic Disorders and Syndromes
  • Lymphatic Disorders and Treatments
  • Cancer Mechanisms and Therapy
  • Drug Transport and Resistance Mechanisms
  • Complement system in diseases
  • Autoimmune and Inflammatory Disorders Research
  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • Blood groups and transfusion
  • Therapeutic Uses of Natural Elements
  • Homicide, Infanticide, and Child Abuse

Subang Jaya Medical Centre
2005-2022

National University of Malaysia
2013

University of Malaya
1989-2005

Hospital Kuala Lumpur
1993-1997

University Malaya Medical Centre
1989

Abstract Pregnancy following idiopathic aplastic anaemia is rare and difficult to manage because of life-threatening episodes bleeding infections. Only a handful cases has been reported in the literature. The pregnancies were unsuccessful majority. present report describes patient with moderately severe who was managed intensive haematological support leading delivery healthy infant by caesarean section. Despite platelet transfusion refractoriness as result transfusions prior pregnancy,...

10.1136/pgmj.71.840.625 article EN Postgraduate Medical Journal 1995-10-01

Aim To retrospectively report the clinical outcomes of non-Hodgkin's Lymphoma (NHL) patients post high dose therapy (HDT) with autologous haematopoietic stem cell transplant (AHSCT) and determine whether upfront transplant, which is a first-line consolidative treatment induction chemotherapy, would be feasible modality in resource-limited country. Methods The medical records for NHL who had undergone HDT followed by AHSCT from October 1997 to November 2016 two hospitals Klang Valley,...

10.1111/ijcp.13823 article EN International Journal of Clinical Practice 2020-11-17

There is scarce information available in regards to the survival outcome of non-Hodgkin lymphoma (NHL) South East Asia regions. Reports on High dose therapy followed by autologous haematopoietic stem cell transplantation (AHSCT) were mainly from developed countries. In this study, we present NHL patients treated with AHSCT year 1997 2016 two urban hospitals Malaysia. A total 140 identified, majority whom had B (54.3%). Majority (89.3%) complete remission at AHSCT. The overall (OS) and...

10.22541/au.159200630.09329491 preprint EN Authorea (Authorea) 2020-06-12

Hematopoietic stem cell transplantation (HSCT) is now widely practiced worldwide. It has the potential to cure many hematological diseases, such as acute leukemia and thalassemia. As an emerging country, Malaysia made advancements despite challenges. HSCT evolved rapidly since first pediatric allogeneic case in 1987. The adult was performed 5 years later 1993. Currently, a total of 13 hospitals offer services throughout Malaysia. These include private healthcare services, substantially...

10.31547/bct-2019-017 article EN BLOOD CELL THERAPY / The official journal of APBMT 2020-01-01
Coming Soon ...